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A B S T R A C T
Silent information Regulators (SIRT1) gene stimulates antioxidants’ expression, repairs cells damaged by
oxidative stress (OS), and prevents the cells’ dysfunction. In particular, the role of different Sirtuins, particularly
SIRT1 in reproduction, has been widely studied over the past decade. Decreased SIRT 1 causes mitochondrial
dysfunction by increasing Reactive Oxygen Species (ROS), lipid peroxidation, and DNA damage in both male and
female gametes (Sperms and Oocytes), leading to infertility. In the female reproductive system, SIRT1 regulates
proliferation and apoptosis in granulosa cells (GCs), and its down-regulation is associated with a reduced ovarian
reserve. SIRT1 also modulates the stress response to OS in GCs by targeting a transcription factor vital for ovarian
functions and maintenance.
ROS-mediated damage to spermatozoa’s motility and morphology is responsible for 30–80% of men’s infertility
cases. High levels of ROS can cause damage to deoxyribo nucleic acid (DNA) in the nucleus and mitochondria,
lipid peroxidation, apoptosis, inactivation of enzymes, and oxidation of proteins in spermatozoa. SIRT 1 is a
cardioprotective molecule that prevents atherosclerosis by modulating various mechanisms such as endothelial
injury due to impaired nitric oxide (NO) production, inflammation, OS, and regulation of autophagy. SIRT 1 is
abundantly expressed in tubular cells and podocytes. It is also found to be highly expressed in aquaporin 2
positive cells in the distal nephron suggesting its involvement in sodium and water handling. SIRT1 improves
insulin resistance by reducing OS and regulating mitochondrial biogenesis and function. It also decreases
adiposity and lipogenesis and increases fatty acid oxidation. So, its involvement in the multiple pathways ensures
its unique role in reproductive and metabolic derangement mechanisms.
1. Introduction
Sirtuins (NAD dependant-deacylase) are involved in the deacetylation
of histones and transcriptional factors regulating the cell cycle, resistance
to oxidative stress, and metabolism. They are located in all essential parts
of the cell, including the nucleus, cytoplasm, and mitochondria (Morris,
2013; Merksamer et al., 2013). SIRT1 has been called the “sensor” and
“guardian of the redox state” in granulosa cells and oocytes(3). A vast
range of cellular activities is controlled by SIRT1, including programmed
cell death, autophagy, cell migration, and differentiation. This review
aims to gather information about crosstalk between SIRT1 and OS,
reproductive and metabolic functions (Table 1, Fig. 1).
2. Mechanism of action of sirtuins
Sirtuins have been found to affect the reproductive physiology of
females by acting as antioxidants against the ROS. They act as sensors
and protectors of the redox environment within the ovarian granulosa
cells. SIRT1, expressed at small concentrations in oocytes, is a chief
participant during oogenesis that extends to metaphase II (MII). SIRT2,
chiefly located in the cytoplasm, transitorily migrates to the nucleus to
control chromatin condensation and regulate the cell cycle. SIRT3
functions during fertilization and the primary embryonic growth by
participating in energy metabolism (Kawamura et al., 2010). SIRT5
prevents the cell from oxidative damage by activating the enzymes which
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are NADPH-producing. SIRT6 is associated with telomere stability;
however, SIRT7 co-activates ribosomal DNA transcription.
SIRT1 is also known to repair cells that have been damaged due to OS,
thus preventing dysfunction of ovarian cells (Pillarisetti, 2008); it does
this by deacetylation of members of the forkhead-box transcription fac-
tors (FOXO) family (Brunet et al., 2004). SIRT1 also promotes mito-
chondrial biogenesis by activating the peroxisome proliferator-activated
receptor co-activator PGC1-α in the presence of NAD (Nakao et al., 2019).
SIRT1 utilizes visfatin for accomplishing its effect against the oxidants.
Visfatin is known to be an essential element in regulating the oxidative
environment of the oocytes. However, SIRT1 is also responsible for
regulating the function and expression of MnSOD (Peck et al., 2010).
3. SIRT1, OS, and stress
A recent study stated that Proopiomelanocortin (POMC) neuron
specific ablation of SIRT1 did not change POMC, Adrenocorticotropic
hormone (ACTH), and alpha-melanocyte-stimulating hormone (αMSH)
levels (Ramadori et al., 2010; Yamamoto and Takahashi, 2018). The
pro-CRH is acted upon by prohormone convertases 1 and 2 (PC1 and
PC2) post-translationally. In the Para Ventricular Nuclei (PVN), SIRT1
elevates the PC2 levels, which in turn increases the concentration of
active CRH, stimulating the HPA axis (Toorie et al., 2016). There is a
probability that SIRT1 indirectly controls the HPA axis by regulating the
PC1 and PC2 concentrations. Moreover, Resveratrol also augmented the
expression and prolongation of the half-life of P450scc in the suprarenal
gland, resulting in the increase of cortisol secretion from the adrenal
cortical sites (Yamamoto and Takahashi, 2018; Li et al., 2012).
Infertile couples are stressed because of the situation, and thus, their
stress hormones are higher than normal. These disturbed hormones have
an indirect effect on the HOP axis via OS, causing infertility. However,
the cascade of high-stress hormones could be triggered by conditions
other than infertility and can lead to subfertility. SIRT1 deficiency could
be one reason.
4. SIRT1, OS and female reproduction
In particular, the role of different Sirtuins, particularly SIRT1 in
reproduction, has been widely studied over the past decade. In the female
reproductive system, SIRT1 regulates proliferation and apoptosis in
granulosa cells (GCs), especially during the follicular atretic phase, and
its down-regulation is associated with a reduced ovarian reserve (Tatone
et al., 2018a). Porcine GCs transfected with SIRT1 showed increased
proliferation markers proposing the role of SIRT1 in GC differentiation
and luteinization (Sirotkin et al., 2014). SIRT1 modulates the stress
response to OS in GCs by targeting FOXL2, a transcription factor vital for
ovarian functions and maintenance (Benayoun et al., 2011).
It also delays postovulatory oocyte aging through its anti-oxidative
actions and by improving mitochondrial function (Liang et al., 2018).
SIRT1 is highly expressed in the hypothalamus, particularly in the GnRH
neurons (Di Sante et al., 2015). Its role in the HPG axis has been iden-
tified in knockout mice, which had decreased GnRH expression and, in
turn, decreased levels of both FSH and LH (Kolthur-Seetharam et al.,
2009a). Hypogonadotropic hypogonadism has also been reported in such
mice due to GnRH neuronal migration (Di Sante et al., 2015).
Increasing SIRT1 activity can improve fertility by conserving ovarian
reserve, regulating proliferation and apoptosis of GCs, and protecting
against OS. Sirtuin-mediated regulation of energy homeostasis, mito-
chondrial biogenesis, and chromatin remodeling can further be explored
to identify its effectiveness in females with PCOS, diabetes, endometri-
osis, xenobiotic stress, and aging. Sirtuin-based signaling can, therefore,
be applied as diagnostic tools and potential targets for therapeutic ap-
plications in reproductive medicine (Tatone et al., 2018a). Regulation of
insulin sensitivity and maintenance of the energy balance (Xiong et al.,
2011) via various pathways renders SIRT1 different from other family
members.
Table 1
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is a main transcriptional co-
activator that regulates
glucose metabolism in the
liver at the level of gene
transcription
Rodgers JT et al.
(Rodgers et al., 2005)
Increased obesity SIRT1 decreases adiposity and
lipogenesis and increases fatty
acid oxidation by repressing
the PPARγ, inhibiting the
CRTC2 or TORC2 and
deacetylating and activating
the PGC-1α
Picard et al. (Bordone
et al., 2006); Nemoto
et al., (Nemoto et al.,






SIRT 1 is a cardioprotective
molecule that prevents
atherosclerosis by modulating
endothelial injury due to




Donato et al. (Donato
et al., 2015)
Renal Injury SIRT1 inhibits sodium
reabsorption in the inner
medullary collecting ducts by
repressing the transcription of
the epithelial sodium channel,
down regulates angiotensin II
type 1 receptor in vascular
smooth muscle cells and also
promotes the resistance of
RMICs to oxidative stress and
injury through its anti-
oxidative properties




Recently, SIRT1, SIRT2 and
SIRT3 have emerged as
protectors of oocyte against
postovulatory aging.
It also delays postovulatory
oocyte aging through its anti-
oxidative actions and by
improving mitochondrial
function.
Tatone C et al. (Tatone
et al., 2018a)





deficiency of SIRT1 leads to
decrease in number of
spermatozoa:
1.By ubiquitination and
subsequent degradation of the
transcription factor FOXO3a
2.By decreasing the caspase 3
and 9, thus reducing the
caspase mediated apoptosis
Wang et al. (Wang et al.,
2015); Li et al. (Li et al.,
2016); Zhou et al. (Zhou
et al., 2017)
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5. SIRT 1, OS and oocytes/ovaries
SIRT1 plays its role as an effective modulator in mammals’ oocytes at
diverse phases of follicle maturation by modifying mitochondrial
mechanisms to synthesize energy (13, 20). Within the oocytes, the
mitochondrial enzymes (including MnSOD) are deacylated by SIRT1(21,
22).
This has already been proven that SIRT1 demonstrates a front-line
defense mechanism against the ROS through the FoxO3a-MnSod axis in
the mouse’s immature ovarian oocytes at the germinal vesicle phase (GV)
(Di Emidio et al., 2014).
These conclusions validate SIRT1 as a principal and precise phar-
macological focus against ROS destroying oocytes (Liu et al., 2012). They
also propose SIRT1 to be a pharmacological excitation that might be an
appropriate line to advance to treat improved oocyte achievement during
OS-mediated physiological disruptions, especially in early aged ovaries
(Di Emidio et al., 2014).
6. SIRT1, OS, and subfertility
Nicotinamide and acetyl group of substrate reacts enzymatically in
the presence of SIRT1, forming O-acetyl ADP ribose as a metabolite. This
reaction generates NAD with helps the ovarian cells to grow (Pillarisetti,
2008).
In mice model, Sirtuin regulation has been related to fertility
(McBurney et al., 2003). Mice strains with Sirtuin deficiency demonstrate
a tiny phenotype with growth-related defects and early postnatal expiries
(Coussens et al., 2008). In cases of SIRT1 deficiency, Resveratrol, an in-
direct SIRT1 activator, demonstrated a vital role of SIRT1 as an activator
of steroidogenesis during luteinization and differentiation of granulosa
cells (Morita et al., 2012).
7. SIRT 1, OS and mitochondria
Cytochrome P450, NADPH oxidase family (28) and mitochondria
generate ROS during the physiological electron transport chain reactions.
Mitochondrial ability to maintain the ROS is achieved by the total redox
environment and its compartmentalized reduction activity, which is
dependent on the antioxidant buffers (electron donors) (NADPH, NADH
and glutathione) (Miranda-Vizuete et al., 2000). However, the antioxi-
dants like manganese superoxide along with peroxides and mitochon-
drial thioredoxin cycle system counter balances the negativity. This
stability is very much demanded for the maturation of ovarian follicles;
otherwise, the effects are detrimental (30). SIRT1 inhibition leads to an
inability of the oocyte to up-regulate SOD2 and counteract the increase in
ROS under increased OS(23).
Manganese superoxide converts the injurious free radicals (superox-
ides), which are capable of damaging the DNA, to oxygen molecule and
hydrogen peroxide. Further, catalase converts hydrogen peroxide to
water and oxygen. Normal oxidant generation is essential for various
physiologic functions of the reproductive system (ovary), including
ovarian steroid genesis, oocyte maturation, ovulation, blastocysts for-
mation, implantation, luteolysis and luteal maintenance in pregnancy.
However, change in this normality becomes another important regulator
of ovarian germ cell growth and stromal cell physiology (31).
8. SIRT1, oxidative stress, and male infertility
Sperm cells are highly vulnerable to oxidative damages as the testicular
tissue has an increased rate of cell division, mitochondrial oxygen and
unsaturated fatty acid consumption, and low oxygen pressure due to the
weakness of the testicular artery (Asadi et al., 2017). SIRT1 has also been
found to have a significant role in the male reproductive system. SIRT1 is
involved in spermatogenesis by influencing specific functions of male
germ cells, Sertoli cells, and Leydig cells (Tatone et al., 2018b). Most of
these effects are due to the antioxidant effect of SIRT1 in spermatogenesis.
Mostefa et al. reported OS and SIRT1 deficiency as the cause of male
infertility in patients with varicocele. As varicocele also causes oxidative
stress; however, the deficiency of SIRT1 has added effect of decreased
seminal antioxidant defenses (Agarwal et al., 2015; Mostafa et al., 2015).
The low expression of seminal SIRT1 expression has significant positive
correlations with concentration, total motility, and normal morphology of
Fig. 1. Effect of decreased expression of SIRT1 on infertility: Decreased expression of SIRT1, causing mitochondrial dysfunction by increase in Reactive Oxygen
Species (ROS), lipid peroxidation and DNA damage in both male and female gametes (Sperms and Oocytes) leading to infertility.
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sperm (Mostafa et al., 2018). There are many mechanisms by which SIRT1
modulates the antioxidant outcomes. One of these antioxidant effects is
that it protects spermatozoa from apoptosis by hydrogen peroxide via
ubiquitination and subsequent degradation of the transcription factor
FOXO3a (Wang et al., 2015; Li et al., 2016). SIRT1 also exerts an
anti-apoptotic effect by deacetylation of lysine residues on proteins,
affecting their functions, including transcriptional activity, DNA binding,
protein binding, protein stability, and translocation. SIRT1 also inhibits
the microglial-derived factors via the p53-caspase-3-dependent mecha-
nism, thus abolishing the caspase-mediated apoptosis (Zhou et al., 2017;
Ye et al., 2013). Resveratrol reverses this effect.
In addition to this, SIRT1 increases the expression of Bcl-2 and de-
creases the expression of BAX, thus regulating the mitochondrial mem-
brane permeability, mitochondrial function, and cytochrome c release
(Zhou et al., 2017; Leber et al., 2007). This is the mechanism through
which decrease expression of SIRT1 affects sperm motility.
An increase in SIRT1 expression also increases nitric oxide synthase
activity in vascular endothelial cells (ECs) and maintains microenviron-
ment homeostasis, nutrient exchange, host defense reactions, and vaso-
dilation. The mechanisms underlying this protective effect involve Sirt1/
FOXOs, Sirt1/NF-κB, Sirt1/NOX, Sirt1/SOD, and Sirt1/eNOs pathways
(Nakata et al., 2012; Zhang et al., 2017). SIRT1 plays a significant role in
regulating autophagy, a stress-induced catabolic process, by increasing
mitochondrial metabolism (Ou et al., 2014). SIRT1 also has a physio-
logical function in acrosome biogenesis during spermiogenesis by
modulating autophagic flux (Liu et al., 2017). SIRT1selectively activates
LC3, a key initiator of autophagy. LC3 controls major steps in the auto-
phagic pathway, including autophagic membrane growth, autophagic
cargo recognition, and the fusion of autophagosomes with lysosomes
(Huang et al., 2015). Depletion of SIRT1 in germ cells causes accumu-
lation of acetylated LC3 in the spermatid nucleus, which affects acrosome
biogenesis. These spermatogenesis changes lead to an increased pro-
portion of abnormal spermatozoa in the SIRT1-deficient mice (Liu et al.,
2013).
Li et al. suggested that SIRT1 and signal transducer and activator of
transcription 3 (STAT3) have a synergistic effect against oxidative stress
(Li et al., 2015). SIRT1 is required for regulating normal postnatal testic-
ular development and spermatogenesis through hypothalamus-pituitary
gonadotropin (HPG) signaling (Kolthur-Seetharam et al., 2009b). SIRT1
is required for histone to protamine transition and altered chromatin
condensation. Ultimately, this leads to decreased fecundity (Bell et al.,
2014).
It appears that many mechanisms are underlying the function of
SIRT1 against oxidative stress in spermatozoa. The low expression of
seminal SIRT1 expression has significant positive correlations with con-
centration, total motility, and normal morphology of sperm.
9. Metabolic effects of SIRT1
9.1. SIRT1, OS and glucose metabolism
SIRT1 affects insulin secretion and glucose homeostasis through its
interaction with PGC-1a. (Rodgers et al., 2005). PGC-1a is one of the
main transcriptional activators of glucose metabolism in the liver. SIRT1
has been shown to deacetylate PGC-1a and hence regulate hepatic
glucose metabolism. Experiments on mice pancreatic beta cells have
shown that SIRT1 up-regulates insulin secretion in response to glucose
stimulation and enhances glucose tolerance (Moynihan et al., 2005).
Also, SIRT1 knockout mice display lower serum glucose levels than
wild-type mice (Bordone et al., 2006). SIRT1 also reduces obesity by
suppressing PPARg, which leads to reduced fat deposition in adipocytes
(Picard et al., 2004). This, in turn, reduces obesity, which leads to the
resolution of insulin resistance and type 2 Diabetes.
Insulin resistance and obesity are two characteristic features of PCOS,
an endocrine disorder commonly found in reproductive-age females (Tao
et al., 2015). Compared to fertile females, females with PCOS have a
higher BMI and lower levels of SIRT1. Rehana et al. hypothesized that the
use of Metformin in PCOS patients might act by the correction of OS
caused by SIRT1 malfunction (Rehman et al., 2018). Adipose tissue can
also secrete angiotensin II, which stimulates Nicotinamide Adenine
Dinucleotide Phosphate (NADPH) oxidase activity, the major ROS pro-
duction route in adipocytes (Hukshorn et al., 2004). Thus, it can be
concluded that females with low levels of SIRT1 cannot counter the
excess oxidant load produced by additional adipocytes and, conse-
quently, develop increased OS.
9.2. SIRT 1, OS and obesity
Obesity is defined as a pathological increase in body fat. It is charac-
terized by an imbalance between the intake and expenditure of calories
(Mutch and Clement, 2006). Various molecules have been involved in the
pathogenesis of obesity, of which SIRT1 has been an important one. SIRT1
decreases adiposity and lipogenesis and increases fatty acid oxidation by
repressing the peroxisomeproliferator-activated receptor-gamma (PPARγ),
inhibiting the CREB-regulated transcription co-activator 2 (CRTC2 or
TORC2) and deacetylating and activating the peroxisome
proliferator-activated receptor-gamma co-activator 1-alpha (PGC-1α)
(Picard et al., 2004; Nemoto et al., 2005; Kilic et al., 2015). Various studies
have demonstrated low-grade, chronic inflammation in obesity, and this
inflammation is the result of bothmacrophage recruitment and production
of ROS (Xu et al., 2003). SIRT1 alters these macrophages’ recruitment and
polarization into adipose tissues by modulating several adipokines’
expression and secretion and decreasing the risk of obesity (Hui et al.,
2017).
Extremes of body weight negatively affect females’ fecundability and
adversely impacts fetuses and embryos through oxidative mechanisms.
Moderate exercise may assist obese women in reducing weight and
restoring their fertility. Lifestyle factors such as maternal smoking,
alcohol consumption, and use of recreational drugs stimulate the pro-
duction of unfavorable amounts of ROS, leading to OS, which renders
physiological processes of female reproduction and the fetus vulnerable
to oxidant-induced damage. Exposure to environmental pollution can
also give rise to excessive OS during pregnancy and has increasingly
raised concern about the impact of pollutant exposure on maternal and
fetal health.
9.3. SIRT1, OS and insulin resistance
Insulin resistance is defined as the resistance of target tissues such as
skeletal muscles, adipocytes, and liver to insulin stimulation and is most
often implicated in developing type II diabetes mellitus (Zhang et al.,
2015). Variousmechanisms of the pathogenesis of insulin resistance have
been proposed, of which mitochondrial dysfunction has been a popular
one. Mitochondrial abnormalities, particularly mitochondrial complex 1
lead to increased reactive oxygen species production (ROS) (Szendroedi
et al., 2011). Increased ROS leads to increased oxidative stress, impairs
both B cell function and insulin signaling, thereby accelerating insulin
resistance (Gerber and Rutter, 2017; Morgan et al., 2007). SIRT1 restores
mitochondrial complex 1 activity via the SIRT1-SIRT3-mitochondrial
complex 1 pathway and alleviates mitochondrial dysfunction and OS,
improving insulin resistance (Zhang et al., 2015). SIRT1 also reduces OS
by overexpression of anti-oxidative enzymes, including MnSOD and
Catalase (St-Pierre et al., 2006). Thus, SIRT1 may improve insulin
resistance by reducing oxidative stress and regulating mitochondrial
biogenesis and function.
9.4. SIRT 1, OS and cardiovascular disease
Cardiovascular disease due to atherosclerosis is the leading cause of
death worldwide (Go et al., 2013). SIRT 1 is a cardioprotective molecule
that prevents atherosclerosis by modulating the various mechanisms
involved in its pathogenesis, namely endothelial injury due to impaired
F. Alam et al. Current Research in Physiology 4 (2021) 119–124
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nitric oxide (NO) production, inflammation, OS, and regulation of
autophagy (Donato et al., 2015). SIRT1 increases endothelial NO pro-
duction by activating eNOS, leading to vasodilation and reversing
endothelial dysfunction (Ota et al., 2010). SIRT 1 also suppresses
inflammation by downregulating NF-κB activity through deacetylation
(Kitada et al., 2016). SIRT 1 is noted to promote autophagy via AMPK
activation, which reduces OS and inflammation and suppresses foam cell
production, thereby hindering atherosclerosis progress (Luo et al., 2019).
Lastly, SIRT1 reduces OS, a major causative factor of atherosclerosis, by
its interplay with the FOXO transcription factors and up-regulation of
anti-oxidative enzymes (Luo et al., 2014). Aging is an independent risk
factor for CVD. Thus, SIRT1 acts as a cardioprotective molecule by pro-
tecting the heart from aging and ischemia/reperfusion injury, resists
hypertrophic and oxidative stresses, inhibits cardiomyocyte apoptosis,
and regulates cardiac energy metabolism.
9.5. SIRT1, OS and related renal physiology
Sirtuins, including SIRT1 present in the renal system, support the
production of sufficient energy throughout the different tubular and
glomerular compartments to carry out all these processes (73). SIRT 1 is
abundantly expressed in tubular cells and podocytes. It is also found to be
highly expressed in aquaporin 2 positive cells in the distal nephron of rats,
suggesting its involvement in sodium and water handling (Zhang et al.,
2009). SIRT1 inhibits sodium reabsorption in the inner medullary col-
lecting ducts by repressing the epithelial sodium channel’s transcription
(eNAC) (Zhang et al., 2009). SIRT1 also acts on the renin-angiotensin
system; its overexpression downregulates angiotensin II type 1 receptor
(AT1R) in vascular smooth muscle cells (Miyazaki et al., 2008).
In contrast, a reduced expression of SIRT1 is associated with the
increased transcription of AT1R in podocytes (Chandel et al., 2017). The
renal medulla is a high OS zone; SIRT 1 has been shown to promote the
resistance of renal medullary interstitial (RMICs) cells to oxidative stress
and injury through its anti-oxidative properties (He et al., 2010). One of the
mechanisms through which it does so is by increasing COX-2 and PGE2
production in RMICs (He et al., 2010). Hence, in conditions that cause
ureteral obstruction, SIRT1 overexpression protects the medulla from the
increased oxidative stress-induced inflammation and fibrosis by induction
ofCOX2. SIRT1alsoplays a protective role in acute kidney injury; increased
ROS and mitochondrial damage are necrosis features in AKI. SIRT1 acti-
vation can alleviate the increased OS and mitochondrial dysfunction,
thereby protecting the kidney against AKI-mediated necrosis (Hasegawa
et al., 2010;GuanandHao, 2016). Thus, renal pathologies could result from
SIRT1 mutations due to uncontrolled ROS produced by the renal tissue’s
highly functional mitochondria. Evaluation of SIRT1 mutation becomes an
important factor in patients with recurrent renal pathologies.
10. Conclusion
It seems that SIRT1 has multiple roles in human pathophysiology and
biochemical pathways, from its involvement in reproduction to several
metabolic functions. Further research is needed to confirm its exact role
in the body’s various mechanisms. There is a need to design such phar-
macologic interventions that affect SIRT1 activity to bring it back to an
optimal level. So, many deleterious conditions or metabolic de-
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